APA (7th ed.) Citation

Guven, D. C., Sahin, T. K., Akın, S., & Uckun, F. M. (2022). Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination. The oncologist (Dayton, Ohio), 27(4), e357-e361. https://doi.org/10.1093/oncolo/oyac032

Chicago Style (17th ed.) Citation

Guven, Deniz C., Taha K. Sahin, Serkan Akın, and Fatih M. Uckun. "Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination." The Oncologist (Dayton, Ohio) 27, no. 4 (2022): e357-e361. https://doi.org/10.1093/oncolo/oyac032.

MLA (9th ed.) Citation

Guven, Deniz C., et al. "Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination." The Oncologist (Dayton, Ohio), vol. 27, no. 4, 2022, pp. e357-e361, https://doi.org/10.1093/oncolo/oyac032.